Table 2. Associations between cannabis use in pregnancy and maternal and infant outcomes, BC, ON and NL, 2012–2019.
Maternal and Infant Outcomes | Cannabis use | No cannabis use | p-value | Unadjusted Odds Ratios (95% CI) | Adjusted Oddsa Ratios (95% CI) | Adjusted Oddsa Ratios (95% CI)–Female Infant | Adjusted Oddsa Ratios (95% CI)–Male Infant | Interaction p-value | ||
---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | |||||||
Preterm (<37 weeks) | 1751 | 9.1 | 41128 | 4.2 | <0.0001 | 2.30 | 1.85 | 1.88 | 1.82 | 0.05 |
[2.19–2.42] | [1.74–1.94] | [1.74–2.04] | [1.69–1.96] | |||||||
Spontaneous | 1097 | 5.7 | 24004 | 2.4 | <0.0001 | 2.47 | 1.80 | 1.94 | 1.70 | 0.04 |
[2.32–2.63] | [1.68–1.93] | [1.76–2.14] | [1.55–1.86] | |||||||
Medically | 654 | 3.4 | 17124 | 1.7 | <0.0001 | 2.06 | 1.94 | 1.80 | 2.06 | 0.1 |
Indicated | [1.90–2.23] | [1.77–2.12] | [1.59–2.05] | [1.83–2.30] | ||||||
Very preterm (<32 weeks) | 198 | 1.0 | 3992 | 0.4 | <0.0001 | 2.56 | 1.73 | 1.87 | 1.62 | 0.3 |
[2.21–2.95] | [1.48–2.02] | [1.50–2.33] | [1.31–2.00] | |||||||
Low birthweight (<2500g) | 1292 | 6.7 | 23942 | 2.4 | <0.0001 | 2.89 | 1.90 | 1.88 | 1.93 | 0.7 |
[2.73–3.06] | [1.79–2.03] | [1.73–2.05] | [1.77–2.11] | |||||||
SGA (<10th percentile) | 2360 | 12.3 | 73128 | 7.4 | <0.0001 | 1.72 | 1.21 | 1.28 | 1.16 | 0.03 |
[1.65–1.80] | [1.16–1.27] | [1.20–1.37] | [1.08–1.23] | |||||||
LGA (>90th percentile) | 1547 | 8.1 | 95430 | 9.7 | <0.0001 | 0.86 | 1.06 | 1.09 | 1.03 | 0.3 |
[0.82–0.91] | [1.01–1.12] | [1.01–1.18] | [0.96–1.12] | |||||||
Stillbirth | 60 | 0.3 | 1997 | 0.2 | 0.001 | 1.53 | 1.15 | 1.14 | 1.13 | 1.0 |
[1.18–1.98] | [0.86–1.53] | [0.74–1.75] | [0.77–1.66] | |||||||
Any major congenital anomaly | 246 | 1.2 | 6287 | 0.6 | <0.0001 | 1.99 | 1.71 | 1.89 | 1.63 | 0.3 |
[1.75–2.26] | [1.49–1.97] | [1.51–2.36] | [1.38–1.93] | |||||||
Caesarean section | 4324 | 22.9 | 240013 | 24.7 | <0.0001 | 0.90 | 1.13 | * | * | * |
[0.87–0.93] | [1.09–1.17] | |||||||||
Gestational diabetes | 883 | 4.6 | 56317 | 5.7 | <0.0001 | 0.79 | 1.32 | * | * | * |
[0.74–0.85] | [1.23–1.42]b | |||||||||
Gestational hypertension | 455 | 2.4 | 21231 | 2.2 | 0.048 | 1.10 | 1.10 | * | * | * |
[1.001–1.21] | [0.99–1.22]c |
*Comparisons by infant sex were only conducted for infant outcomes.
a Models adjusted for other substance use, maternal age, pre-pregnancy BMI, rural maternal residence, parity, QAIPPE score, pre-existing diabetes, chronic hypertension, gestational diabetes and gestational hypertension.
b Models adjusted for other substance use, maternal age, pre-pregnancy BMI, rural maternal residence, parity, QAIPPE score, pre-existing diabetes, chronic hypertension and gestational hypertension.
c Models adjusted for other substance use, maternal age, pre-pregnancy BMI, rural maternal residence, parity, QAIPPE score, pre-existing diabetes, chronic hypertension and gestational diabetes.